Guggenheim Capital LLC Vericel Corp Transaction History

Guggenheim Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$46.35 - $59.75 $275,643 - $355,333	-5,947 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$47.2 - $67.81 $28,933 - $41,567	-613 Reduced 9.34%	5,947 $312,000
Q1 2021 May 13, 2021	BUY	$30.93 - $59.48 $202,900 - $390,188	6,560 New	6,560 $364,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.